LTZ Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch LTZ Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma (NCT07121946) | LTZ Therapeutics, Inc. | 2026-01-29 |
Track LTZ Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.